Nanoparticles for gene therapy improve
A new cross-institutional collaboration has led to a promising ovarian cancer formulation... more >>

Nanoparticles target tumors and dodge the immune system
KI-derived nanotechnology therapy that targets prostate cancer is to begin patient clinical trials next year... more >>

Possible origins of pancreatic cancer revealed
KI scientists have identified which cells can give rise to this disease, an observation that may aid in earlier detection... more >>

Micro-RNA mediate metastasis suppression
KI team provide new molecular insight into how microRNAs suppress tumor metastasis... more >>

Koch Institute collaborative teams expand to include physicists
5-year grant from the NCI will fund these interdisciplinary projects... more >>

Defining the combination of genetic circumstances that make certain lung cancers more treatable
Specific genetic backgrounds identify subgroups highly sensitive to NF-kappaB inhibition... more >>

KI director Tyler Jacks elected to Institute of Medicine
Jacks will be part of NAS agency that advices government on medical issues... more >>

KI member receives award for cancer pathways research
Paul Marks awards prize for discovery of key cancer pathways... more >>

Three KI cancer researchers are selected by NIH for innovative grants
Special awards that target high-risk, high-return projects... more >>

KI's new approach to cancer research is a turning point
Biologists and engineers collaborate to change cancer into chronic disease... more >>

Killing the killer: cancer stem cells
MIT team discovers a new way to rapidly identify cancer stem cell specific drugs... more >>

Fast tracking personalized medicine
Using tumor mutation profiling to predict chemo success... more >>

KI Researchers take aim at Ovarian Cancer
New nanoparticle-based therapy may prove useful in fighting late-stage tumors... more >>

Robert Langer Lab launches collaboration with Korea University
New KI international collaboration to focus on high-impact biomedical research... more >>

Nova on PBS profiles KI's Sangeeta Bhatia
Highlights on work at the interface of biology and engineering... more >>

mTOR in the spotlight again; this time at the junction of aging & cancer
In Forbes, KI's David Sabatini helps to explain why... more >>

KI Member Robert Weinberg's lab reports in Cell how a small RNA suppresses metastasis
High levels of a tiny fragment of RNA appear to suppress the spread of aggressive breast cancer... more >>

KI's Sangeeta Bhatia and colleagues awarded Stand Up 2 Cancer (SU2C) funding
Circulating Tumor Cells Chip project selected as one of five "dream teams"... more >>

Tyler Jacks on The Today Show announces Stand Up 2 Cancer (SU2C) funding
Five "dream teams" awarded $73M in funding to support highly collaborative projects... more >>

Wellcome Trust and MIT launch new interdisciplinary research fellowship program
Grants to support work at the interfaces between biology/medicine and engineering/computation/chemistry/physics... more >>

Implantable monitoring device can detect tumor growth
New prototype shows success in one month study... more >>

Gold "nanorod" formulations show promise in cancer detection and treatment
KI researchers find remotely activated nanoparticles effective in treating cancer... more >>

The Economist reports on medicine going digital
KI research combining biology and engineering is paving the way... more >>

KI Director is elected to prestigious National Academy of Sciences
Tyler Jacks is one of 72 newly elected to NAS for distinguished and on-going achievements in original science. more >>

"Fuzzy logic" used by MIT team to predict potential treatment responses
Using the new model reveals different and novel information about cellular pathways... more >>

New biomarker may lead to a test that can predict aggressive cancer
KI scientist is part of team that has identified a new biomarker for metastatic potential... more >>

Forbes reports on the emerging role of artificial livers in developing new drugs
KI researcher's micro-livers are providing new tools to fast track drug development... more >>

KI researchers report on a major advance in reprogramming skin cells into stem cells
For the first time potential cancer-causing genes can be removed during reprogramming... more >>

Student in KI/HST lab wins Lemelson-MIT prize
$30,000 prize awarded to Bhatia Lab student for innovative cancer research... more >>

Major KI milestone hit on time and on budget
Completion of purpose-built facility enters next phase... video >>

KI faculty share latest technologies at World Economic Forum IdeasLab Annual Meeting
Sangeeta Bhatia and Michael Cima shared their latest research at an international meeting in Davos-Klosters, Switzerland... more >>

Using RNAi to tackle ovarian cancer
KI researchers report new effective ways block ovarian tumors from growing and spreading... more >>

KI professor among 10 "Women to Watch"
Mass High Tech newspaper named KI's Sangeeta Bhatia one of ten "Women to Watch" leaders... more >>

Therapeutic Antibodies
KI researchers show that antibodies do not need sugar attachments for potency... more >>

Too much of a good thing?
Cells with extra chromosomes share detrimental traits... more >>

How to win the war against cancer
The power of massive, integrated programs must be brought to bear... more >>

New KI computational models to individualize cancer treatment
In Cell, KI researcher describe how computer simulations can reveal the inner workings and vulnerabilities of a cancer... more >>

Prostate cancers can escape immunity
KI researchers describe potent immuno-suppressive activity of prostate cancer microenvironment... more >>

TIME Magazine takes critical look at new trends in cancer research
KI's integrative research approach highlighted as a leading example... more >>

Progress made in predicting patients' response to chemo
Koch Institute plays important role in uncovering why people react differently to chemotherapy... more >>